Research and Innovation
Piloting a FLASH Radiotherapy Beam for Treatment of Cancer
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
What Types of Early-phase Trials are Open Now at NCCC?
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.
Where Do Prouty Donations Go? Spring, 2020
Programming machine learning for cervical cancer screening, aiding survival of cancer-fighting immune cells, and measuring clinician emotion during difficult conversations. These are just some of the new cancer research studies funded by The Prouty.
Capturing and Explaining the “Eye Flash Phenomenon”
What are the flashes of light patients report seeing during brain radiotherapy, even with their eyes closed? Norris Cotton Cancer Center scientists record this phenomenon for the first time and provide an explanation.
What Are Early-Phase Clinical Trials?
In this Q&A series, Jason Faris, MD, director of the Early-Phase Trials Program at Norris Cotton Cancer Center explains what early-phase clinical trials are and why they are so important to the advancement of cancer care.
Where Do Prouty Donations Go? Fall 2019
Research in therapies for drug-resistant cancers, technologies to study “guardian” proteins, adapting robotic surgery tools and the world’s fastest single-photon camera are underway, funded by The Prouty.
Dartmouth-Hitchcock Health to Fund $1M Annually for Dedicated Cancer Clinician Research Time
A new program will create dedicated time to assist Dartmouth-Hitchcock Health clinicians in researching causes of and cures for cancer.
Modernizing Cancer Care with Machine Learning
Dartmouth researchers are leading the way on cutting-edge computer technologies that could provide clinicians with great new tools for cancer screening, diagnosis, prognosis and more.
Where Do Prouty Donations Go? Spring, 2019
Studies on post-weight-loss surgery diets, access to health insurance and a particular vitamin’s valuable action in cancer treatment are underway thanks to research funds raised at the 36th Prouty.
New Machine Learning Method Could Spare Some Women from Unnecessary Breast Surgery
A new machine learning method can predict the likelihood that a high-risk type of breast lesion is cancerous, potentially saving some women from unnecessary breast surgeries and overtreatment.